Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Prepaid Assets: 2022-2024

Historic Prepaid Assets for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Dec 2024 value amounting to $24.3 million.

  • NewAmsterdam Pharma Co N.V's Prepaid Assets rose 85.37% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year increase of 85.37%. This contributed to the annual value of $24.3 million for FY2024, which is 282.78% up from last year.
  • NewAmsterdam Pharma Co N.V's Prepaid Assets amounted to $24.3 million in FY2024, which was up 282.78% from $6.3 million recorded in FY2023.
  • In the past 5 years, NewAmsterdam Pharma Co N.V's Prepaid Assets registered a high of $24.3 million during FY2024, and its lowest value of $6.3 million during FY2023.
  • In the last 3 years, NewAmsterdam Pharma Co N.V's Prepaid Assets had a median value of $10.3 million in 2022 and averaged $13.6 million.
  • Per our database at Business Quant, NewAmsterdam Pharma Co N.V's Prepaid Assets tumbled by 38.14% in 2023 and then soared by 282.78% in 2024.
  • Yearly analysis of 3 years shows NewAmsterdam Pharma Co N.V's Prepaid Assets stood at $10.3 million in 2022, then plummeted by 38.14% to $6.3 million in 2023, then skyrocketed by 282.78% to $24.3 million in 2024.